维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Kalloger"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Ovarian carcinoma subtypes are different disease:implications for biomarker studies显示文摘	Kobel M Kalloger S E Boyd N	2008	PLos Med2008，5，12：	1
2	Detection of lung perfusion abnormalities using computed tomography in a porcine model of pulmonary embolism显示文摘	Screaton NJ Coxson HO Kalloger SE	2003	J Thorac Imaging2003，18，：	1
3	A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary 显示文摘	Krbel M Kalloger SE Carrick J	2009	Am J Surg Pathol2009，33，1：	1
4	Kisspeptin and GPR54immunoreactivity in a cohort of518patients defines favourable prognosis and clear cell subtype in ovarian carcinoma显示文摘	Prentice L M Klausen C Kalloger S	2007	BMC Medicine2007，5，：	1
5	The prognostic significance of elongation factor eEF1A2 in ovarian cancer显示文摘	Pinke DE Kalloger SE Francetic T		0，，03：	1
6	Biomarker-based ovarian carcinoma typing:a histologic investigation in the ovarian tumor tissue analysis consortium显示文摘	Kobel M Kalloger S E Lee S	2013	Cancer Epidemiol Biomarkers Prev2013，22，10：	1
7	Ovarian carcinoma subtypes are different diseases:implications for biomarker studies显示文摘	K(o)bel M Kalloger SE Boyd N	2008	PLoS Med2008，5，12：	1
8	Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma显示文摘	Prentice LM Klausen C Kalloger S		0，，：	1
9	Differences in tumor type in low-stage versus high stage ovarian carcinomas 显示文摘	Kohel M Kalloger SE Huntsman DG	2010	Int J Gynecol Pathol2010，29，3：	1
10	Ovarian carcinoma sub-types are different disease:implications for biomarker studies显示文摘	Kbel M Kalloger SE Boyd N	2008	PloS Med2008，5，12：	1
11	HER2/neu testing in gas- tric cancer by immunolaistocbemistry: assessment of interlaboratory variation显示文摘	Sheffield BS Garratt J Kalloger SE	2014	Arch Pathol Lab Med2014，138，11：	1
12	Biomarker expression in pelvic high-grade serous eareinoma: comparison of ovarian and o- mental sites 显示文摘	Kobel M Turbin D Kalloger SE	2011	Int J Gyneeol Pathol2011，30，4：	1
13	Amplification of 1 1q13 in ovarian carcinoma 显示文摘	Brown LA Kalloger SE Miller MA	2008	Genes Chromosomes Cancer2008，47，6：	1
14	FOXL2 Is a Sensitive and Specific Marker for Sex Cord-Stromal Tumors of the Ovary显示文摘	Osama M. Al-Agha Hassan F. Huwait Christine Chow Winnie Yang Janine Senz Steve E. Kalloger David G. Huntsman Robert H. Young C. Blake Gilks	2011	The American Journal of Surgical Pathology2011，，：	1
15	Ovarian carcinoma subtypes are different disease:implications for biomarker studies显示文摘	KOBEL M KALLOGER S E BOYD N	2008	PLos Med2008，5，12：	1
16	Ovarian careinoma subtypes are different disease : implications for biomarker studies 显示文摘	Kobel M Kalloger SE Boyd N	2008	PLos Med2008，5，：	1
17	The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma显示文摘	Jane A. Cipollone Marcia L. Graves Martin K?bel Steve E. Kalloger Tak Poon C. Blake Gilks Kelly M. McNagny Calvin D. Roskelley	2012	Clinical & Experimental Metastasis2012，，3：	1
18	Ovarian carcinoma sub- types are different diseases: implications for biomarker studies 显示文摘	Kobel M Kalloger S E Boyd N	2008	PLoS Medicine2008，5，12：	1
19	Detection of lung perfusion abnormalities using computed tomography in a por- cine model of pulmonary embolism显示文摘	Screaton N J Coxson H O Kalloger S E	2003	J Thorac Imaging2003，，18：	1
20	Ovarian carcinoma subtypes are different diseases: implications Ibr biomarker studies显示文摘	Kobel M Kalloger SE Boyd N	2008	PLoS Med2008，5，12：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示